Infectious skin diseases caused either by bacteria, fungi or viruses, account
for an important burden in dermatology practice. The number is increasing due to
higher percentage of immunocompromised patients. Although in many instances they
can be successfully treated with topical agents, sometimes systemic antimicrobial agents
are indicated. This occurs in extensive or complicated skin and soft tissue infections,
tinea capitis, onychomycosis, genital herpes or herpes zoster. Besides, some
antibacterial agents have been shown to have antiinflammatory properties and they have
been successfully used for the treatment of noninfectious skin diseases.
New drugs are continuously developing due to increasing multi-drugs resistant
microorganisms, especially in the context of immunocompromised patients.
Appropriate antimicrobial selection requires the consideration of multiple factors,
including conditions of the host, the disease and the drug. Clinicians should know the
properties, indications and adverse events related to the old and new antimicrobial
agents in order to choose the correct option.This chapter summarizes the characteristics
of systemic antimicrobial agents commonly used in dermatology.
Keywords: Anti-infective agents, antibacterial agents, antifungal agents,
antiparasitic agents, antiviral agents, antitreponemal agents, antitubercular agents,
leprostatic agents, administration, oral, infusions, parenteral, skin and connective
tissue diseases, skin.
